.
BioEnterprise

Cleveland HeartLab Adds Two Patents for the Myeloperoxidase Test

Cleveland HeartLab adds two additional patents to its intellectual property position for the Myeloperoxidase test, a key predictor of major cardiac events.

Read More  >
Hello. Add your message here.